Researchers from the University of Toronto and the Broad Institute have developed a high-throughput imaging platform to examine nearly 3,500 mutations and their effects on protein location.
The study, published in Cell, found that approximately one in six disease-causing mutations resulted in proteins being misdirected to incorrect cellular locations. This frequency of mislocalization was higher than previously thought, occurring almost as often as protein instability or altered protein interactions.
Jessica Lacoste, co-lead author of the study, emphasized the importance of this research in bridging the gap between identifying genetic mutations and understanding their cellular consequences. “Technological advances in genetic sequencing have allowed researchers to identify thousands of protein mutations that cause disease,” she said. “We are now able to identify these mutations in patients at the clinic, but we have no idea what their consequences are for cellular processes. This study was meant to help bridge that gap in knowledge.”
Search Antibodies Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.
Surprisingly, the primary causes of protein mislocalization were found to be breakdowns in protein stability and the loss of membrane integration ability, rather than disruptions to protein interactions or trafficking signals as initially expected.
Professor Mikko Taipale, co-principal investigator, highlighted the significance of their work: "We've created the first large-scale map to visualize the impact of mutations on protein localization within the cell." This comprehensive map provides insights into disease severity caused by certain mutations and enhances understanding of less-studied mutations.
The researchers have made their protein mislocalization database publicly available as a resource for further scientific exploration. Dr. Anne Carpenter, another co-principal investigator, suggested that this data could be particularly useful in identifying compounds to correct protein localization in rare diseases.
The study's findings have important implications for understanding and potentially treating various genetic disorders, as demonstrated by current therapies for cystic fibrosis that address protein mislocalization issues.